RPG Life Sciences Intrinsic Value
RPGLIFE • Healthcare
Current Stock Price
₹1890.80
Primary Intrinsic Value
₹1960.64
Market Cap
₹2458 Cr
-35.9%
Downside
Median Value
₹1212.31
Value Range
₹570 - ₹1961
Assessment
Trading Above Calculated Value
Safety Margin
-56.0%
RPGLIFE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1960.64 | ₹1568.51 - ₹2352.77 | +3.7% | EPS: ₹89.12, Sector P/E: 22x |
| Book Value Method | asset | ₹816.92 | ₹735.23 - ₹898.61 | -56.8% | Book Value/Share: ₹408.46, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1212.31 | ₹1091.08 - ₹1333.54 | -35.9% | Revenue/Share: ₹606.15, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1692.31 | ₹1523.08 - ₹1861.54 | -10.5% | EBITDA: ₹220.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹756.32 | ₹605.06 - ₹907.58 | -60.0% | CF Growth: 7.7%, Discount: 15% |
| PEG Ratio Method | growth | ₹570.37 | ₹513.33 - ₹627.41 | -69.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1376.90 | ₹1239.21 - ₹1514.59 | -27.2% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹1821.54 | ₹1639.39 - ₹2003.69 | -3.7% | ROE: 27.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹816.92 | ₹735.23 - ₹898.61 | -56.8% | EPS: ₹89.12, BVPS: ₹408.46 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
RPGLIFE Intrinsic Value Analysis
What is the intrinsic value of RPGLIFE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of RPG Life Sciences (RPGLIFE) is ₹1212.31 (median value). With the current market price of ₹1890.80, this represents a -35.9% variance from our estimated fair value.
The valuation range spans from ₹570.37 to ₹1960.64, indicating ₹570.37 - ₹1960.64.
Is RPGLIFE undervalued or overvalued?
Based on our multi-method analysis, RPG Life Sciences (RPGLIFE) appears to be trading above calculated value by approximately 35.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 66.43 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 27.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 21.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.20x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for RPG Life Sciences
Additional stock information and data for RPGLIFE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹78 Cr | ₹57 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹94 Cr | ₹55 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹91 Cr | ₹38 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹65 Cr | ₹48 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹58 Cr | ₹54 Cr | Positive Free Cash Flow | 8/10 |